Cortisol_NN
resistance_NN
in_IN
acquired_VBN
immunodeficiency_NN
syndrome_NN
._.

This_DT
study_NN
concerns_VBZ
9_CD
iv_NN
drug_NN
abusers_NNS
with_IN
acquired_VBN
immunodeficiency_NN
syndrome_NN
-LRB-_-LRB-
AIDS_NN
-RRB-_-RRB-
who_WP
developed_VBD
hypercortisolism_NN
without_IN
the_DT
clinical_JJ
signs_NNS
or_CC
metabolic_JJ
consequences_NNS
of_IN
hypercortisolism_NN
._.

All_DT
patients_NNS
were_VBD
characterized_VBN
by_IN
an_DT
Addisonian_JJ
picture_NN
-LRB-_-LRB-
weakness_NN
,_,
weight_NN
loss_NN
,_,
hypotension_NN
,_,
hyponatremia_NN
,_,
and_CC
intense_JJ
mucocutaneous_JJ
melanosis_NN
-RRB-_-RRB-
._.

An_DT
acquired_VBN
form_NN
of_IN
peripheral_JJ
resistance_NN
to_TO
glucocorticoids_NNS
was_VBD
suspected_VBN
._.

We_PRP
,_,
therefore_RB
,_,
examined_VBD
glucocorticoid_NN
receptor_NN
characteristics_NNS
on_IN
mononuclear_JJ
leukocytes_NNS
by_IN
measuring_JJ
-LCB-_-LRB-
3H-RCB-dexamethasone_NN
binding_NN
and_CC
the_DT
effect_NN
of_IN
dexamethasone_NN
on_IN
-LCB-_-LRB-
3H-RCB-thymidine_NN
incorporation_NN
,_,
which_WDT
is_VBZ
one_CD
of_IN
the_DT
effects_NNS
of_IN
glucocorticoid_NN
receptor_NN
activation_NN
._.

Glucocorticoid_NN
receptor_NN
density_NN
was_VBD
increased_VBN
in_IN
AIDS_NN
patients_NNS
with_IN
an_DT
Addisonian_JJ
picture_NN
-LRB-_-LRB-
group_NN
1_CD
;_:
16.2_CD
+_CC
\/_CD
-_:
9.4_CD
fmol\/million_NN
cells_NNS
-RRB-_-RRB-
compared_VBN
to_TO
values_NNS
in_IN
12_CD
AIDS_NN
patients_NNS
without_IN
an_DT
Addisonian_JJ
picture_NN
-LRB-_-LRB-
group_NN
2_CD
;_:
6.05_NN
+_CC
\/_NN
-_:
2.6_CD
fmol\/million_NN
cells_NNS
;_:
P_NN
less_JJR
than_IN
0.01_CD
-RRB-_-RRB-
and_CC
sex_NN
-_:
and_CC
age-matched_JJ
controls_NNS
-LRB-_-LRB-
3.15_CD
+_CC
\/_CD
-_:
2.3_CD
fmol\/million_NN
cells_NNS
;_:
P_NN
less_JJR
than_IN
0.01_CD
-RRB-_-RRB-
._.

The_DT
affinity_NN
of_IN
glucocorticoid_NN
receptors_NNS
-LRB-_-LRB-
Kd_NN
-RRB-_-RRB-
was_VBD
strikingly_RB
decreased_VBN
-LRB-_-LRB-
9.36_CD
+_CC
\/_NN
-_:
3.44_CD
nM_NN
in_IN
group_NN
1_CD
;_:
3.2_CD
+_CC
\/_JJ
-_:
1.5_CD
nM_NN
in_IN
group_NN
2_CD
;_:
2.0_CD
+_CC
\/_NN
-_:
0.8_CD
nM_NN
in_IN
controls_NNS
;_:
P_NN
less_JJR
than_IN
0.01_CD
-RRB-_-RRB-
._.

-LCB-_-LRB-
3H-RCB-Thymidine_NN
incorporation_NN
was_VBD
decreased_VBN
dose-dependently_RB
by_IN
dexamethasone_NN
in_IN
controls_NNS
and_CC
patients_NNS
;_:
the_DT
effect_NN
was_VBD
significantly_RB
blunted_VBN
-LRB-_-LRB-
P_NN
less_JJR
than_IN
0.05_CD
-RRB-_-RRB-
in_IN
group_NN
1_CD
patients_NNS
,_,
which_WDT
suggests_VBZ
that_IN
activation_NN
of_IN
glucocorticoid_NN
receptor_NN
is_VBZ
impaired_JJ
as_IN
a_DT
result_NN
of_IN
the_DT
glucocorticoid_NN
receptor_NN
abnormality_NN
._.

In_IN
conclusion_NN
,_,
AIDS_NN
patients_NNS
with_IN
hypercortisolism_NN
and_CC
clinical_JJ
features_NNS
of_IN
peripheral_JJ
resistance_NN
to_TO
glucocorticoids_NNS
are_VBP
characterized_VBN
by_IN
abnormal_JJ
glucocorticoid_NN
receptors_NNS
on_IN
lymphocytes_NNS
._.

Resistance_NN
to_TO
glucocorticoids_NNS
implies_VBZ
a_DT
complex_JJ
change_NN
in_IN
immune-endocrine_JJ
function_NN
,_,
which_WDT
may_MD
be_VB
important_JJ
in_IN
the_DT
course_NN
of_IN
immunodeficiency_NN
syndrome_NN
._.

